Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy affects cancer risks in transgender individuals differently than in cisgender people, and more research is needed to understand these risks and improve cancer screening guidelines.

Bilateral Orchiectomy effectively reduces the need for anti-androgen medication in most transgender females.

The transgender community in India has specific skin care needs and struggles to access dermatological services due to discrimination and financial issues.

Stress from being transgender is linked to higher blood pressure at night and more inflammation, which may affect heart health.

Social rejection can harm long-term mental health in transgender individuals.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

MTS effectively improves hair density and thickness in menopausal women with hair loss.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

The document concludes that careful planning and execution of facial gender affirmation surgery after at least 12 months of hormonal therapy can improve the quality of life for transgender individuals.

Transgender and gender diverse youth often have skin issues like acne and scarring, but few get referred to dermatologists.

Male pattern baldness may indicate arterial stiffness in transgender men on long-term testosterone therapy.

Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.

Adding estrogen increased bone mass in a transsexual man undergoing hormone therapy.

Facial contouring is crucial for the satisfaction and well-being of Chinese transgender females.

The document concludes that facial feminization surgery improves psychological well-being and social acceptance for transgender individuals.

Dermatology trainees lack standardized guidelines and education for treating testosterone-induced skin conditions in transmasculine individuals.

Gynecologists should learn about transgender care to provide the best service.

Cross-sex hormone treatment in transsexual individuals helps understand how sex hormones affect diseases like heart disease and diabetes.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

Inclusive and culturally competent healthcare is crucial for transgender and non-binary individuals.

Gender-affirming hormone therapy in South Korea aligns with international guidelines and has specific side effects.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Progesterone may help trans women with breast development and health, but more research is needed.

The tool kit helps transit agencies ensure safety by managing employees' medication use.

A hair transplant using hair from the back of the head and pubic area was successful in creating a feminine hairline for a male-to-female transgender person.

Forehead reduction and orbital contouring are important for satisfactory facial feminization in transgender females, with high satisfaction and low long-term problems.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

Testosterone therapy in transgender men can lead to hair loss, with the risk increasing over time and influenced by family history.

Transgender individuals face insurance barriers to gender-affirming surgery, needing policy reforms for better access.